| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 3.9K | 10.8% |
| Total Income | 3.9K | 11.4% |
| Expenditure | 3.5K | 10.0% |
| PBT | 426.37 | 22.3% |
| Net Profit | 282.62 | 32.8% |
| OPM | 17.55% | 17.67pp |
| NPM | 7.22% | 1.12pp |
| EPS | 5.92 | 30.4% |
Bharat Forge Reports Q4 & FY25 Earnings: Revenues of Rs.2,163 crores, 100 bps Higher Margin in Q4; Full Year Revenue at Rs.8,844 crores with 28.5% Margin
09 May 2025 · 9 May 2025, 05:27 pm
Summary
Bharat Forge has reported its Q4 & FY25 earnings with a stable performance in Q4, having revenues of Rs.2,163 crores and a 100 bps higher margin compared to the last quarter. The full year revenue was at Rs.8,844 crores with a margin of 28.5%. The Company secured new business worth Rs.6,959 crores across all key businesses. The CAPEX for Indian operations was Rs.750 crores in FY25. The Company is working on restructuring options for European steel operations and expects to see a 15% to 20% growth in defense in FY26. The Company is also hopeful for revenue progression in E-mobility this year.
Key Highlights
- 1
Stable performance in Q4 with revenues of Rs.2,163 crores and a 100 bps higher margin compared to the last quarter
- 2
Full year revenue at Rs.8,844 crores with a margin of 28.5%, a 100-basis points expansion in margins vis-a-vis last year
- 3
New business worth Rs.6,959 crores secured across all key businesses
- 4
CAPEX for Indian operations was Rs.750 crores in FY25
- 5
Expects to see a 15% to 20% growth in defense in FY26
- 6
Hopeful for revenue progression in E-mobility this year
Management Comments
Amit Kalyani
We have had a reasonable performance in FY 25 with 100 basis points margin improvement on a strong robust balance sheet. Few things will stand out are the fact that the business is becoming more diversified and resilient.
Kedar Dixit
Standalone EBITDA in Q4 grew by 6.7% vis-a-vis Q3 at Rs.629 crores, translating in a margin of 29.1% which is of 100 bps higher than last quarter.
Informational and educational content only. Not investment advice.